Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort.

Other clinical factors, including BMI of ≥19.8 kg/m 2 (HR, 0.68; 95% CI, 0.40-1.1; P =.156) and baseline albumin level of ≥3.1 g/dL (HR, 2.02; 95% CI, 0.82-4.95; P = .125) showed trends, but they did not reach statistical significance in the multivariate model ( Table 2 ).

also in 111,027 other papers